Moreover, SDC3 mediates localization of TFPI—a molecule endowed with tumor suppressor activity [40,41]—to the surface of endothelial, smooth muscle, and breast cancer cells [41], which may contribute to an antitumoral effect of SDC3 in the breast cancer microenvironment. The gene discussed is TFPI; the disease is breast carcinoma.